MJA
MJA

Pharmaceutical preparations

Medical education / Lessons from practice

Reversal of dabigatran with idarucizumab in hyperacute stroke: a new paradigm?

Amy Ting, Abhay R Venkat, Yash Gawarikar and Ronak Patel

Med J Aust 2019; 210 (7): 302-303.e1

Narrative reviews

Pre‐exposure prophylaxis for HIV prevention during pregnancy and lactation: forget not the women and children

Lisa Horgan, Christopher C Blyth, Asha C Bowen, David A Nolan and Andrew P McLean‐Tooke

Med J Aust 2019; 210 (6): 281-284

Letters

Intercontinental translocation of latent multidrug‐resistant tuberculosis to Australia demonstrated by whole genome sequencing

Sanjay S Gautam, Greg Haug, Louise A Cooley, Micheál Mac Aogáin and Ronan F O'Toole

Med J Aust 2019; 210 (5): 236

Guideline summary

Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary

Emily Reeve, Barbara Farrell, Wade Thompson, Nathan Herrmann, Ingrid Sketris, Parker J Magin, Lynn Chenoweth, Mary Gorman, Lyntara Quirke, Graeme Bethune and Sarah N Hilmer

Med J Aust 2019; 210 (4): 174-179

Medical education / Lessons from practice

Glaucoma caused by topical corticosteroid application to the eyelids

Helen HL Chan and John F Salmon

Med J Aust 2019; 210 (4): 142-153

Letters

Unintended consequences of a cautious approach to e‐cigarette laws

Christian Catalano, Noel E Cranswick, Jeff Robinson, Joanne Grindlay, Mick Creati, Margie H Danchin, Nicola Williams and Amanda Gwee

Med J Aust 2019; 210 (3): 143-144

Perspectives

Let's talk about cytotoxic chemotherapy dosing: unravelling adjustments and off‐protocol prescribing

Angelina Tjokrowidjaja, Elizabeth Hovey and Craig R Lewis

Med J Aust 2019; 210 (2): 65-66

Editorials

Pregabalin misuse: the next wave of prescription medication problems

Bridin Murnion and Katherine M Conigrave

Med J Aust 2019; 210 (2): 72-73

Research letter

Concomitant prescribing of opioids and benzodiazepines in Australia, 2012–2017

Gillian E Caughey, Svetla Gadzhanova, Sepehr Shakib and Elizabeth E Roughead

Med J Aust 2019; 210 (1): 39-40 Free

Perspective

Regulatory and other responses to the pharmaceutical opioid problem

Gabrielle Campbell, Nicholas Lintzeris, Natasa Gisev, Briony Larance, Sallie Pearson and Louisa Degenhardt

Med J Aust 2019; 210 (1): 6-8

Research

Intensive lipid‐lowering therapy in the 12 months after an acute coronary syndrome in Australia: an observational analysis

David Brieger, Mario D'Souza, Karice Hyun, James C Weaver and Leonard Kritharides

Med J Aust 2019; 210 (2): 80-85 Free

Research

Pregabalin misuse‐related ambulance attendances in Victoria, 2012–2017: characteristics of patients and attendances

Rose Crossin, Debbie Scott, Shalini Arunogiri, Karen Smith, Paul M Dietze and Dan I Lubman

Med J Aust 2019; 210 (2): 75-79 Free

Perspective

Medicinal cannabis for chemotherapy-induced nausea and vomiting: prescribing with limited evidence

Antony J Mersiades, Martin R Stockler, Ian N Olver and Peter Grimison

Med J Aust 2019; 210 (1): 11-12

Editorials

Deprescribing proton pump inhibitors: why, when and how

Peter Bytzer

Med J Aust 2018; 209 (10): 436-438

Meta-analysis

Helicobacter pylori infection and the risk of upper gastrointestinal bleeding in low dose aspirin users: systematic review and meta-analysis

Justin CH Ng and Neville David Yeomans

Med J Aust 2018; 209 (7): 306-311

Letters

Adverse effects of modified release oxycodone/naloxone in patients with moderate to severe liver impairment

Venessa Pattullo, Gavin G Pattullo and Simone I Strasser

Med J Aust 2018; 209 (6): 279-280

Editorials

The challenges in providing safe, effective, affordable cannabis-based medicines for unapproved indications

Wayne D Hall and Michael Farrell

Med J Aust 2018; 209 (5): 209-210

Perspectives

Improving drug allergy management in Australia: education, communication and accurate information

Michaela Lucas, Richard KS Loh and William B Smith

Med J Aust 2019; 210 (2): 62-64

Letters

An era of untreatable gonorrhoea?

Brett Sutton and Mihaela Ivan

Med J Aust 2018; 209 (4): 188

Research

Cannabidiol for treating drug-resistant epilepsy in children: the New South Wales experience

Kerrie-Anne Chen, Michelle Farrar, Michael Cardamone, Deepak Gill, Robert Smith, Christopher T Cowell, Linda Truong and John A Lawson

Med J Aust 2018; 209 (5): 217-221 Free

Research letter

Safety of cannabidiol prescribed for children with refractory epilepsy

Jeremy L Freeman

Med J Aust 2018; 209 (5): 228-229 Free

Research

Medicinal cannabis in Australia, 2016: the Cannabis as Medicine Survey (CAMS-16)

Nicholas Lintzeris, Jessica Driels, Natalie Elias, Jonathon C Arnold, Iain S McGregor and David J Allsop

Med J Aust 2018; 209 (5): 211-216 Free

Perspectives

Potential implications of the new American hypertension guidelines in Australia

Garry LR Jennings, Bronwyn A Kingwell and Erin Hoare

Med J Aust 2018; 209 (3): 108-109

Perspectives

Glycaemic control apps for diabetes: lifting the lid

Rahul Barmanray and Esther Briganti

Med J Aust 2018; 209 (10): 426-427

Editorials

Poisoning and poisoning advice: availability, toxico-vigilance and research

Geoffrey K Isbister

Med J Aust 2018; 209 (2): 65-66